Karvy Stock Broking has recommended an outperformer rating on Dr Reddy’s Labs with a price target of Rs 925 in its report dated June 11, 2009. “Dr Reddys Lab has received the USFDA approval for Omeprazole OTC. Shipment of this product will commence in Q2 FY2010. This is a USD…
Dr Reddys Labs an outperformer, target of Rs 925: Karvy
Posted on: June 11th 2009 in Brokerage Recommendations.
Nitin Fire Protection an outperformer: Karvy
Posted on: June 9th 2009 in Brokerage Recommendations.
Karvy Stock Broking has rated Nitin Fire Protection Industries as an outperformer with a price target of Rs 373 in its June 8, 2009 research report. “Nitin Fire Protection Industries (NFPIL) operates in two broad business segments: 1) fire protection, safety and security and 2) hig…
PVR an outperformer: Karvy Stock Broking
Posted on: June 2nd 2009 in Brokerage Recommendations.
Karvy Stock Broking has rated PVR as an outperformer with a target price of Rs 153 in its June 2, 2009 research report. “Apart from PVR Pictures, the rest of the subsidiaries commenced operations in FY09 and are getting stabilized. FY10 will also see a full year of operations of th…
Dishman Pharma an outperformer: Karvy
Posted on: May 28th 2009 in Brokerage Recommendations.
Karvy Stock Broking has downgraded its rating on Dishman Pharmaceuticals & Chemicals from buy to an outperformer with a target price of Rs 220 in its May 28,2009 research report. “The management has given the guidance of 15% …
Latest Query
- by Sam
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis